Position in DSGN
as of Mar 31, 2026
· filed May 20, 2026
Position Value
$17,161,287
+$2,032,257 QoQ
Shares Held
1,612,903
0.0% QoQ
Ownership
2.58%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vivo Capital, LLC holds $1,160,013,312 across 42 Biotechnology names. DSGN ranks #24 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ERAS |
Erasca, Inc.
|
12,151,480 | $196,610,946 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
338,895 | $109,188,580 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
1,334,418 | $70,350,516 | |
| 4 | TRVI |
Trevi Therapeutics, Inc.
|
5,094,668 | $60,779,389 | |
| 5 | DBVT |
DBV Technologies S.A.
|
2,667,569 | $55,725,516 | |
| 6 | CMPX |
Compass Therapeutics, Inc.
|
9,545,466 | $50,495,515 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
2,154,780 | $45,077,997 | |
| 8 | SABS |
SAB Biotherapeutics, Inc.
|
11,420,000 | $43,738,600 |
All Filings in DSGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,161,287 | 1,612,903 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $15,129,030 | 1,612,903 | Shares | Sole | 2026-02-13 | |
| 2022-06-30 | $6,672,246 | 476,589 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,696,912 | 476,589 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,368,517 | 530,991 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,800,257 | 530,991 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,561,410 | 530,991 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,876,630 | 530,991 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||